Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Total operating income				$ 70,769
General and administrative costs:
Compensation	546,095	119,146	1,667,748	289,154
Professional fees	269,543	92,508	816,009	301,244
Information technology	15,661	7,012	29,267	16,247
General and administrative-other	56,940	145,244	197,302	208,204
Total general and administrative costs	888,239	363,910	2,710,326	814,849
Research and development costs, net of grants amounting to $489,798 and $704,162, for the three months ended September 30 and $1,807,706 and $2,265,408, for the nine months ended September 30	723,487	27,936	1,238,463	67,095
Total operating costs	1,611,726	391,846	3,948,789	881,944
Net operating loss	(1,611,726)	(391,846)	(3,948,789)	(811,175)
Other income (expense):
Interest expense, net	(44,647)		(74,429)	100
Change in fair value of SAFE		(128,750)		(128,750)
Net loss before income taxes	(1,656,373)	(520,596)	(4,023,218)	(939,825)
Income taxes			2,143
Net loss	$ (1,656,373)	$ (520,596)	$ (4,025,361)	$ (939,825)
Net loss per common share - basic	$ (0.27)	$ (0.08)	$ (0.64)	$ (0.15)
Net loss per common share - diluted	$ (0.27)	$ (0.08)	$ (0.64)	$ (0.15)
Weighted average of common shares outstanding - basic	6,252,349	6,250,002	6,251,158	6,250,002
Weighted average of common shares outstanding - diluted	6,252,349	6,250,002	6,251,158	6,250,002